4.6 Article

Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

A reanalysis of pain crises data from the pivotal L-glutamine in sickle cell disease trial

Ahmar U. Zaidi et al.

Summary: The reanalysis of the L-glutamine phase 3 trial in sickle cell disease showed consistent and statistically significant outcomes with a 45% reduction in VOC rates. These results are informative for clinicians evaluating the effects of different SCD therapeutic options based on VOC as the primary endpoint.

CONTEMPORARY CLINICAL TRIALS (2021)

Review Medicine, Research & Experimental

Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events

Tim Jang et al.

Summary: VOC remains the most common reason for presentation in SCD patients, but current treatments to shorten VOC have had disappointing results. Exploration of the reasons for ineffective monotherapy and consideration of combination approaches with multiple agents may be necessary to target complex downstream pathways of VOC.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Review Medicine, Research & Experimental

L-glutamine for sickle cell disease: Knight or pawn?

Alina Sadaf et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2020)

Review Physiology

Recent Advances in the Treatment of Sickle Cell Disease

Gabriel Salinas Cisneros et al.

FRONTIERS IN PHYSIOLOGY (2020)

Article Medicine, General & Internal

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Pharmacology & Pharmacy

Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease

Nicole E. Cieri-Hutcherson et al.

PHARMACOTHERAPY (2019)

Review Genetics & Heredity

Sickle Cell Anemia and Its Phenotypes

Thomas N. Williams et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19 (2018)

Article Medicine, General & Internal

A Phase 3 Trial of L-Glutamine in Sickle Cell Disease

Yutaka Niihara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Medicine, General & Internal

Sickle cell disease

Russell E. Ware et al.

LANCET (2017)

Article Medicine, General & Internal

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

K. I. Ataga et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medical Laboratory Technology

Lactate dehydrogenase in sickle cell disease

Katia Stankovic Stojanovic et al.

CLINICA CHIMICA ACTA (2016)

Review Respiratory System

Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease

ES Klings et al.

RESPIRATORY RESEARCH (2001)

Article Medicine, General & Internal

Causes and outcomes of the acute chest syndrome in sickle cell disease.

EP Vichinsky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)